Advertisement
Screener

EIDOS THERAPEUTICS, INC. Operating Cash Flow

EIDOS THERAPEUTICS, INC. Operating Cash Flow

EIDOS THERAPEUTICS, INC. reported Operating Cash Flow of -$68.57 million for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.

Discontinued › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-10-29

  • EIDOS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2020-09-30 was -$27.63M, a 351.47% decline year-over-year.
  • EIDOS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2020-06-30 was -$22.06M.
  • EIDOS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$18.88M.
  • EIDOS THERAPEUTICS, INC. net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was -$16.50M.
  • EIDOS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2019 was -$31.65M.
  • EIDOS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2018 was -$33.30M.
  • EIDOS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2017 was -$9.72M.
  • EIDOS THERAPEUTICS, INC. net cash provided by (used in) operating activities for fiscal 2016 was -$2.06M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2020-09-30-$27.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
-$49.69M
derived: sum of 2 quarters · filed 2020-10-29
-$68.57M
10-Q · filed 2020-10-29
-$85.07M
derived: sum of 4 quarters · filed 2020-10-29
2020-06-30-$22.06M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$40.93M
10-Q · filed 2020-08-06
-$57.44M
derived: sum of 3 quarters · filed 2020-08-06
-$46.45M
derived: sum of 4 quarters · filed 2020-10-29
2020-03-31-$18.88M
10-Q · filed 2020-05-08
-$35.38M
derived: sum of 2 quarters · filed 2020-05-08
-$24.39M
derived: sum of 3 quarters · filed 2020-10-29
-$40.42M
derived: sum of 4 quarters · filed 2020-10-29
2019-12-31-$16.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$5.52M
derived: sum of 2 quarters · filed 2020-10-29
-$21.54M
derived: sum of 3 quarters · filed 2020-10-29
-$31.65M
10-K · filed 2020-02-26
2019-09-30$10.99M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
-$5.04M
derived: sum of 2 quarters · filed 2020-10-29
-$15.14M
10-Q · filed 2020-10-29
-$24.74M
derived: sum of 4 quarters · filed 2020-10-29
2019-06-30-$16.02M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$26.13M
10-Q · filed 2020-08-06
-$35.73M
derived: sum of 3 quarters · filed 2020-08-06
-$44.63M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$10.11M
10-Q · filed 2020-05-08
-$19.70M
derived: sum of 2 quarters · filed 2020-05-08
-$28.61M
derived: sum of 3 quarters · filed 2020-05-08
-$37.52M
derived: sum of 4 quarters · filed 2020-05-08
2018-12-31-$9.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$18.50M
derived: sum of 2 quarters · filed 2020-02-26
-$27.41M
derived: sum of 3 quarters · filed 2020-02-26
-$33.30M
10-K · filed 2020-02-26
-$33.14M
10-K · filed 2019-04-15
2018-09-30-$8.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31
-$17.81M
derived: sum of 2 quarters · filed 2019-10-31
-$23.70M
10-Q · filed 2019-10-31
-$27.26M
derived: sum of 4 quarters · filed 2020-02-26
2018-06-30-$8.91M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01
-$14.80M
10-Q · filed 2019-08-01
-$18.36M
derived: sum of 3 quarters · filed 2020-02-26
-$21.18M
derived: sum of 4 quarters · filed 2020-02-26
2018-03-31-$5.89M
10-Q · filed 2019-05-07
-$9.45M
derived: sum of 2 quarters · filed 2020-02-26
-$12.27M
derived: sum of 3 quarters · filed 2020-02-26
2017-12-31-$3.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26
-$6.38M
derived: sum of 2 quarters · filed 2020-02-26
-$9.72M
10-K · filed 2020-02-26
2017-09-30-$2.82M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$6.16M
10-Q · filed 2018-11-06
2017-06-30-$3.34M
10-Q · filed 2018-08-07
2016-12-31-$2.06M
10-K · filed 2019-04-15